🇺🇸 FDA

Company profile · Sponsor

Propanc

Propanc Biopharma

PPCB · NYSE biotech CAMBERWELL, VICTORIA, C3, USA
Pipeline
0
Drugs
0
Patents
3

Quick answer

Propanc (PPCB) is a biotech company. headquartered in CAMBERWELL, VICTORIA, C3, USA. listed on NYSE. NovaPharmaNews links 0 pipeline programs, 0 drugs, and 3 patents to this profile..

Company facts

Ticker PPCB
Exchange NYSE
Company type biotech
Headquarters CAMBERWELL, VICTORIA, C3, USA
SEC CIK 0001517681

Pipeline (0)

No pipeline programs linked yet.

Patents (3)

Search patents →

  1. US 12419938

    Proenzyme composition

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11376313

    Cancer treatment

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10350239

    Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent

    Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Propanc?

Propanc (PPCB) is a biotech company. headquartered in CAMBERWELL, VICTORIA, C3, USA. listed on NYSE. NovaPharmaNews links 0 pipeline programs, 0 drugs, and 3 patents to this profile..

Does Propanc have pipeline programs in our database?

No pipeline programs are currently linked to Propanc. Programs may be added as ClinicalTrials.gov sponsor matching improves — check back or search the global pipeline directory.

Where does Propanc company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.